Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study

Keyphrases

• Moderate to Severe 100%
• Severe Community-acquired Pneumonia 100%
• Clarithromycin 100%
• Length of Hospital Stay 66%
• 30-day Mortality 66%
• CURB-65 Score 66%
• Time to Clinical Stability 66%
• No Significant Difference 33%
• Community-acquired Pneumonia 33%
• Hazard Ratio 33%
• British Thoracic Society 33%
• Oral Route 33%
• β-lactam Antibiotics 33%
• Intensive Care Unit Admission 33%
• Intravenous Therapy 33%
• Admission Time 33%
• Society Guidelines 33%
• Macrolides 33%
• Severe CAP 33%
• Oral Therapy 33%
• Propensity Matching 33%
• ICU Admission 33%

Medicine and Dentistry

• Observational Study 100%
• Community-Acquired Pneumonia 100%
• Clarithromycin 100%
• Intravenous Drug Administration 33%
• Hazard Ratio 33%
• Intensive Care Unit 33%
• Macrolide 33%
• β-Lactam antibiotic 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Observational Study 100%
• Community Acquired Pneumonia 100%
• Clarithromycin 100%
• Beta Lactam Antibiotic 33%
• Intravenous Therapy 33%
• Macrolide 33%